Navigation Links
Lupus Research Institute strategy delivers $30 million in national funding
Date:11/19/2007

NEW YORK, NY The Lupus Research Institute (LRI) strategy of backing innovative investigations into systemic lupus, the autoimmune disease, has now yielded an unprecedented $30 million in large-scale funding from the National Institutes of Health and other government and private sources, an independent progress report has determined.

To date, 36 scientists have completed their novel research grants from the 7-year-old LRIan Institute investment of $9 million. A remarkable 61% of these investigators have now turned their innovative hypotheses into confirmed discoveries, winning $30 million in large-scale grants to advance new scientific approaches to how and why lupus occurs, and what can be done to prevent and treat it.

The LRI has been the leader in seeking and funding unproven but promising scientific hypotheses in lupus, said Mark Shlomchik, MD, PhD, professor of Laboratory Medicine and Immunology at Yale University School of Medicine and a member of the LRI Scientific Advisory Board. Its because the LRI supported these innovative ideas in the first place that successful competition for scarce federal funding was possible.

An estimated 1.5 million Americans, and millions more worldwide, have lupus. Many are young women in the prime of their lives. No one knows why lupus occurs, or how to prevent or cure it. There hasnt been a new treatment approved for lupus in nearly 50 years, and existing medications are often toxic and can have debilitating effects.

LRI Breakthrough Discoveries in Lupus

Since its inception 7 years ago, the Institute has invested $22 million overall in cutting-edge lupus research, and current LRI-supported investigators are poised to capture similar large-scale awards. The Institute supports scientists from wide-ranging specialties who might otherwise not receive funds for their innovative and untested hypotheses in lupus.

In a brief time, LRI scientists have made break
'/>"/>

Contact: Liane Stegmaier
lstegmaier@lupusny.org
212-812-9881
Lupus Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Study identifies genetic risk factor for rheumatoid arthritis, lupus
2. Research shows skeleton to be endocrine organ
3. Newly created cancer stem cells could aid breast cancer research
4. Dominant cholesterol-metabolism ideas challenged by new research
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. Texas researchers and educators head for Antarctica
7. MGH researchers describe new way to identify, evolve novel enzymes
8. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
9. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
10. U of MN researchers discover noninvasive diagnostic tool for brain diseases
11. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...d obesity in the United States is reaching epidemi...ising on daytime and prime time television devoted...bout the role television plays in obesity, a study... Nutrition Education and Behavior examines how fo...contributor to the problem. , Researchers at the...
(Date:11/4/2009)...received more than $10 million in research grants ...stimulus program, bringing thetotal amount of stim...lion. Thirty-three projects achieved stimulus fun...er. , "The university has thoughtfully undertake...rly excellence to federal agency priorities. Thro...
(Date:11/4/2009)...wire/ -- DigitalPersona, Inc., a leader in fingerp...announced that WAND Corporation, a leading supplie...e restaurants, has integrated DigitalPersona techn...ions. WAND,s quick-service customers can now use f...ity and deter unauthorized manager overrides. As...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Income at Risk 3A Unemployment Skyrockets for Those with Disabilities Reports Allsup 59721 1Income at Risk 3A Unemployment Skyrockets for Those with Disabilities Reports Allsup 59721 2Income at Risk 3A Unemployment Skyrockets for Those with Disabilities Reports Allsup 59721 3Income at Risk 3A Unemployment Skyrockets for Those with Disabilities Reports Allsup 59721 4Income at Risk 3A Unemployment Skyrockets for Those with Disabilities Reports Allsup 59721 5New IOF report explains importance of FRAX in osteoporosis management 59716 1New IOF report explains importance of FRAX in osteoporosis management 59716 2Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy 59711 1Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy 59711 2
...ide in designated Special Areas of Conservation th...rnwall, might be at risk from pile driving. The fr...e with their ability to communicate, find food and... their behaviour, health and their ability to bree... might be particularly vulnerable , Recently more...
...nth,s issue of Angiology shows that supplementatio...en-all) improves blood flow to the muscles which s...of 113 participants demonstrated that Pycnogenol s...thletes and healthy, normal individuals. , "With ...a profound breakthrough and extremely significant ...
...e found that a method they developed to screen bod...eir genetic blueprint is twice as accurate at spot...ith a microscope. , The screen, developed by Sar... separates cells from fluid, then sifts through th...sociated with cancer. , Reporting in the June 1 ...
Other Biology News:South Pacific plant may be missing link in evolution of flowering plants 2Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics 2Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics 3Gene screen for breast cancer better than pathologist's 'eye' 2
(Date:11/5/2009)... , Fuel economy ratings for the new 2010 model...conomy.gov web site, which Oak Ridge National Lab...tment of Energy and the U.S. Environmental Protect...t fuel economy list are hybrid electrics, led by t...ist proves that hybrids have gone mainstream," sai...
(Date:11/5/2009)...Newswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq...ts for processing and storing adult stem cells, to...al 2010. ,, For the quarter ended September 30,...on, a 15 percent increase over revenues of $4.5 mi... said the key contributors to the growth in revenu...
(Date:11/5/2009)...ire-FirstCall/ -- Wound Management Technologies, I...nto a Letter of Intent to purchase all healthcare-.... (OTC Bulletin Board: VHGI). The deal provides fo...00,000 shares of WNDM and a royalty agreement for ...logy being acquired from VHGI. WNDM closed at $2...
(Date:11/5/2009)...ecialty firm BioSoteria announced that its Vice Pr...rtified Professional in Learning and Performance&t...for Training and Development (ASTD) Certification ... years of medical communications and health care t...lopment of the company,s online pharmacovigilance ...
Breaking Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4
...S Oncology Adjuvant Trial 9735 at 2007 San, Anton...Cyclophosphamide Improved Overall Survival Ver...c. 13 Results presented at the,30th annual San An...for,women with early stage breast cancer who have ...emotherapy combination of Taxotere(R) (docetaxel),...
...Valvulopathy Permitted to Enroll in 2nd and 3rd ...ment Eliminated, SAN DIEGO, Dec. 13 Arena Pharma...e initiation of patient screening in,the second an...cacy and,safety of its lead drug candidate, lorcas...eight and obese patients. Known as BLOSSOM (Behavi...
... Realty Trust, Inc.,(NYSE: BMR ) today announced ...rd of directors, increasing the board to eight mem...e industry, with a breadth of,ability and experien...operation of large-scale commercial real estate pr...r Board will be invaluable as we continue to,execu...
Other Biology Technology:Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 2Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 4Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 5Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 2Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 3Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 4Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 5Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 6BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board 2BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board 3
...tabilCoat Plus Microsphere/Microarray Stabilizer i...ine protein and other non-toxic chemicals in a PBS... This product contains a combination of 0.02% meth...reservative. StabilCoat Plus Stabilizer provides ...
...Bgene's Protein Purification Plates are designed f...GE gels. The 96-well plates feature two 0.25mm hol... wells remain liquid-tight during incubation of th...otein diffuses from the gel into the buffer. Follo...
...bull; Small design specifically for western blots ...,Trays are specifically designed for staining west...he disposable tray requires less dye and antibodie...ser. Pour spouts in each corner facilitate pouring...
...he Gene Inspector can perform many sophisticated D...oftware is much more than just another sequence an...ne an entire suite of analyses to be performed eac...om style sheets which specify exactly how your out...
Biology Products: